| # | % | |||||
|---|---|---|---|---|---|---|
| 101 | SPRINT CORP | 10,804 | 49,000 | 0.03% | ||
| 102 | ATLANTIC PWR CORP | 15,105 | 37,000 | 0.03% | ||
| 103 | SYNTA PHARMACEUTICALS CORP | 102,742 | 27,000 | 0.02% | ||
| 104 | MANNKIND CORP. | 22,317 | 26,000 | 0.02% | ||
| 105 | GENERAL MOLY INC | 56,160 | 19,000 | 0.01% | ||
| 106 | Apricus Biosciences, Inc. | 25,000 | 10,000 | 0.01% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001663138-16-000003, filed 2016.07.20).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
